首页> Pathology> Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?

Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?

导出 LinkOut

翻译打印收藏纠错

第一作者： Imen,Zawati

第一单位： Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia; Department of Biology, Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia. Electronic address: zawati.imen88@gmail.com.

作者： Imen,Zawati ^[1] ; Yousra,Troujette ^[2] ; Olfa,Adouni ^[3] ; Maroua,Manai ^[4] ; Meriem,Nouira ^[5] ; Karim,Mekki ^[6] ; Mohamed,Manai ^[7] ; Khaled,Rahal ^[8] ; Amor,Gamoudi ^[2]

作者单位： Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia; Department of Biology, Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia. Electronic address: zawati.imen88@gmail.com. ^[1] Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia. ^[2] Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia; Department of Biology, Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia. ^[3] Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia; Laboratory of Transmission, Control and Immunobiology of Infections - LR16IPT02, Pasteur Institute of Tunis, University of Tunis, Tunis, Tunisia. ^[4] Department of Epidemiology and Community Medicine, Charles Nicoles Hospital, Tunis, Tunisia. ^[5] Institut Pascal Clermont-Ferrand, France. ^[6] Department of Biology, Laboratory of Biochemistry and Molecular Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia. ^[7] Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia. ^[8]

关键词 breast cancer neoadjuvant chemotherapy prognosis residual cancer burden residual disease residual proliferative cancer burden

DOI 10.1016/j.pathol.2024.11.014

PMID 40121151

发布时间 2025-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交